Copyright Reports & Markets. All rights reserved.

Global Rare Disease Genetic Testing Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Next-Generation Sequencing (NGS)
    • 1.2.3 Array Technology
    • 1.2.4 PCR-based Testing
    • 1.2.5 Fluorescence in Situ Hybridization (FISH)
    • 1.2.6 Sanger Sequencing
    • 1.2.7 Karyotyping
    • 1.2.8 Others
  • 1.3 Market by Application
    • 1.3.1 Global Rare Disease Genetic Testing Market Share by Application: 2020 VS 2026
    • 1.3.2 Research Laboratories and CROs
    • 1.3.3 Diagnostic Laboratories
    • 1.3.4 Hospitals and Clinics
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Rare Disease Genetic Testing Market Perspective (2015-2026)
  • 2.2 Global Rare Disease Genetic Testing Growth Trends by Regions
    • 2.2.1 Rare Disease Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Rare Disease Genetic Testing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Rare Disease Genetic Testing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Rare Disease Genetic Testing Players by Market Size
    • 3.1.1 Global Top Rare Disease Genetic Testing Players by Revenue (2015-2020)
    • 3.1.2 Global Rare Disease Genetic Testing Revenue Market Share by Players (2015-2020)
  • 3.2 Global Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Rare Disease Genetic Testing Revenue
  • 3.4 Global Rare Disease Genetic Testing Market Concentration Ratio
    • 3.4.1 Global Rare Disease Genetic Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Genetic Testing Revenue in 2019
  • 3.5 Key Players Rare Disease Genetic Testing Area Served
  • 3.6 Key Players Rare Disease Genetic Testing Product Solution and Service
  • 3.7 Date of Enter into Rare Disease Genetic Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Rare Disease Genetic Testing Breakdown Data by Type (2015-2026)

  • 4.1 Global Rare Disease Genetic Testing Historic Market Size by Type (2015-2020)
  • 4.2 Global Rare Disease Genetic Testing Forecasted Market Size by Type (2021-2026)

5 Rare Disease Genetic Testing Breakdown Data by Application (2015-2026)

  • 5.1 Global Rare Disease Genetic Testing Historic Market Size by Application (2015-2020)
  • 5.2 Global Rare Disease Genetic Testing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Rare Disease Genetic Testing Market Size (2015-2026)
  • 6.2 North America Rare Disease Genetic Testing Market Size by Type (2015-2020)
  • 6.3 North America Rare Disease Genetic Testing Market Size by Application (2015-2020)
  • 6.4 North America Rare Disease Genetic Testing Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Rare Disease Genetic Testing Market Size (2015-2026)
  • 7.2 Europe Rare Disease Genetic Testing Market Size by Type (2015-2020)
  • 7.3 Europe Rare Disease Genetic Testing Market Size by Application (2015-2020)
  • 7.4 Europe Rare Disease Genetic Testing Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Rare Disease Genetic Testing Market Size (2015-2026)
  • 8.2 China Rare Disease Genetic Testing Market Size by Type (2015-2020)
  • 8.3 China Rare Disease Genetic Testing Market Size by Application (2015-2020)
  • 8.4 China Rare Disease Genetic Testing Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Rare Disease Genetic Testing Market Size (2015-2026)
  • 9.2 Japan Rare Disease Genetic Testing Market Size by Type (2015-2020)
  • 9.3 Japan Rare Disease Genetic Testing Market Size by Application (2015-2020)
  • 9.4 Japan Rare Disease Genetic Testing Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Rare Disease Genetic Testing Market Size (2015-2026)
  • 10.2 Southeast Asia Rare Disease Genetic Testing Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Rare Disease Genetic Testing Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Rare Disease Genetic Testing Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Quest Diagnostics
    • 11.1.1 Quest Diagnostics Company Details
    • 11.1.2 Quest Diagnostics Business Overview
    • 11.1.3 Quest Diagnostics Rare Disease Genetic Testing Introduction
    • 11.1.4 Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2015-2020))
    • 11.1.5 Quest Diagnostics Recent Development
  • 11.2 Centogene
    • 11.2.1 Centogene Company Details
    • 11.2.2 Centogene Business Overview
    • 11.2.3 Centogene Rare Disease Genetic Testing Introduction
    • 11.2.4 Centogene Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 11.2.5 Centogene Recent Development
  • 11.3 Invitae Corporation
    • 11.3.1 Invitae Corporation Company Details
    • 11.3.2 Invitae Corporation Business Overview
    • 11.3.3 Invitae Corporation Rare Disease Genetic Testing Introduction
    • 11.3.4 Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 11.3.5 Invitae Corporation Recent Development
  • 11.4 3billion
    • 11.4.1 3billion Company Details
    • 11.4.2 3billion Business Overview
    • 11.4.3 3billion Rare Disease Genetic Testing Introduction
    • 11.4.4 3billion Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 11.4.5 3billion Recent Development
  • 11.5 Arup Laboratories
    • 11.5.1 Arup Laboratories Company Details
    • 11.5.2 Arup Laboratories Business Overview
    • 11.5.3 Arup Laboratories Rare Disease Genetic Testing Introduction
    • 11.5.4 Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 11.5.5 Arup Laboratories Recent Development
  • 11.6 Eurofins Scientific
    • 11.6.1 Eurofins Scientific Company Details
    • 11.6.2 Eurofins Scientific Business Overview
    • 11.6.3 Eurofins Scientific Rare Disease Genetic Testing Introduction
    • 11.6.4 Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 11.6.5 Eurofins Scientific Recent Development
  • 11.7 Strand Life Sciences
    • 11.7.1 Strand Life Sciences Company Details
    • 11.7.2 Strand Life Sciences Business Overview
    • 11.7.3 Strand Life Sciences Rare Disease Genetic Testing Introduction
    • 11.7.4 Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 11.7.5 Strand Life Sciences Recent Development
  • 11.8 Ambry Genetics
    • 11.8.1 Ambry Genetics Company Details
    • 11.8.2 Ambry Genetics Business Overview
    • 11.8.3 Ambry Genetics Rare Disease Genetic Testing Introduction
    • 11.8.4 Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 11.8.5 Ambry Genetics Recent Development
  • 11.9 Perkin Elmer
    • 11.9.1 Perkin Elmer Company Details
    • 11.9.2 Perkin Elmer Business Overview
    • 11.9.3 Perkin Elmer Rare Disease Genetic Testing Introduction
    • 11.9.4 Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 11.9.5 Perkin Elmer Recent Development
  • 11.10 Macrogen
    • 11.10.1 Macrogen Company Details
    • 11.10.2 Macrogen Business Overview
    • 11.10.3 Macrogen Rare Disease Genetic Testing Introduction
    • 11.10.4 Macrogen Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 11.10.5 Macrogen Recent Development
  • 11.11 Baylor Genetics
    • 10.11.1 Baylor Genetics Company Details
    • 10.11.2 Baylor Genetics Business Overview
    • 10.11.3 Baylor Genetics Rare Disease Genetic Testing Introduction
    • 10.11.4 Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 10.11.5 Baylor Genetics Recent Development
  • 11.12 Color Genomics
    • 10.12.1 Color Genomics Company Details
    • 10.12.2 Color Genomics Business Overview
    • 10.12.3 Color Genomics Rare Disease Genetic Testing Introduction
    • 10.12.4 Color Genomics Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 10.12.5 Color Genomics Recent Development
  • 11.13 Preventiongenetics
    • 10.13.1 Preventiongenetics Company Details
    • 10.13.2 Preventiongenetics Business Overview
    • 10.13.3 Preventiongenetics Rare Disease Genetic Testing Introduction
    • 10.13.4 Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 10.13.5 Preventiongenetics Recent Development
  • 11.14 Progenity
    • 10.14.1 Progenity Company Details
    • 10.14.2 Progenity Business Overview
    • 10.14.3 Progenity Rare Disease Genetic Testing Introduction
    • 10.14.4 Progenity Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 10.14.5 Progenity Recent Development
  • 11.15 Coopersurgical
    • 10.15.1 Coopersurgical Company Details
    • 10.15.2 Coopersurgical Business Overview
    • 10.15.3 Coopersurgical Rare Disease Genetic Testing Introduction
    • 10.15.4 Coopersurgical Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 10.15.5 Coopersurgical Recent Development
  • 11.16 Fulgent Genetics
    • 10.16.1 Fulgent Genetics Company Details
    • 10.16.2 Fulgent Genetics Business Overview
    • 10.16.3 Fulgent Genetics Rare Disease Genetic Testing Introduction
    • 10.16.4 Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 10.16.5 Fulgent Genetics Recent Development
  • 11.17 Myriad Genetics
    • 10.17.1 Myriad Genetics Company Details
    • 10.17.2 Myriad Genetics Business Overview
    • 10.17.3 Myriad Genetics Rare Disease Genetic Testing Introduction
    • 10.17.4 Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 10.17.5 Myriad Genetics Recent Development
  • 11.18 LabCorp
    • 10.18.1 LabCorp Company Details
    • 10.18.2 LabCorp Business Overview
    • 10.18.3 LabCorp Rare Disease Genetic Testing Introduction
    • 10.18.4 LabCorp Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 10.18.5 LabCorp Recent Development
  • 11.19 Opko Health
    • 10.19.1 Opko Health Company Details
    • 10.19.2 Opko Health Business Overview
    • 10.19.3 Opko Health Rare Disease Genetic Testing Introduction
    • 10.19.4 Opko Health Revenue in Rare Disease Genetic Testing Business (2015-2020)
    • 10.19.5 Opko Health Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Rare Disease Genetic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rare Disease Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Next-Generation Sequencing (NGS)
    Array Technology
    PCR-based Testing
    Fluorescence in Situ Hybridization (FISH)
    Sanger Sequencing
    Karyotyping
    Others

    Market segment by Application, split into
    Research Laboratories and CROs
    Diagnostic Laboratories
    Hospitals and Clinics
    Others

    Based on regional and country-level analysis, the Rare Disease Genetic Testing market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Rare Disease Genetic Testing market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Quest Diagnostics
    Centogene
    Invitae Corporation
    3billion
    Arup Laboratories
    Eurofins Scientific
    Strand Life Sciences
    Ambry Genetics
    Perkin Elmer
    Macrogen
    Baylor Genetics
    Color Genomics
    Preventiongenetics
    Progenity
    Coopersurgical
    Fulgent Genetics
    Myriad Genetics
    LabCorp
    Buy now